THE INSTITUTIONAL BIOSAFETY COMMITTEE (IBC)

In accordance with the NIH Guidelines, the University has established an Institutional Biosafety Committee (IBC) responsible for the review of all research involving recombinant and synthetic nucleic acid molecules and transgenic animals. The IBC is a University-wide standing committee advisory to the Vice President for Research. 

On behalf of the Institution, and in accordance with the NIH Guidelines, the Institutional Biosafety Committee is responsible for oversight and review of rDNA research including independent assessment of: containment levels, laboratory facilities, procedures, practices, health surveillance, and training and expertise of personnel involved in the rDNA research.

Additionally, the IBC provides consultation to the Institution’s research community including faculty, staff, and students, concerning issues of biohazards, laboratory biosafety procedures, and appropriate biological techniques (best practices) to minimize risk and hazard.